Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1

Conditions

Breast Neoplasms 118Neoplasms 110Lung Neoplasms 65Colorectal Neoplasms 52Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Pancreatic Neoplasms 34Melanoma 33Ovarian Neoplasms 29Neoplastic Cells, Circulating 29Head and Neck Neoplasms 27Uterine Cervical Neoplasms 23Multiple Myeloma 20Glioma 20Colonic Neoplasms 20Sarcoma 19Carcinoma, Hepatocellular 19Leukemia, Myeloid, Acute 18Neoplasm Metastasis 17Lymphoma 15Glioblastoma 15Esophageal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Hematologic Neoplasms 14Leukemia 13Endometrial Neoplasms 13Myelodysplastic Syndromes 11Kidney Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11

Interventions

Cytarabine 7Mitoxantrone 3Cyclophosphamide 3venetoclax 2thymoglobulin 2fludarabine phosphate 2fludarabine 2devimistat 2Thiotepa 2Tacrolimus 2Rituximab 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Daunorubicin 2Cladribine 2vosaroxin 1quizartinib 1plerixafor 1pegylated granulocyte colony-stimulating factor 1blinatumomab 1aldesleukin 1Transplantation 1Stem Cell Transplantation 1Sorafenib 1Sirolimus 1Razoxane 1Mycophenolic Acid 1Metformin 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Myeloid × Blood Specimen Collection × Clear all
NCT05854966 2024-09-19

CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Wake Forest University Health Sciences

Phase 2 Withdrawn
Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡